Conference Proceedings

Changes in plasma lipid species following pravastatin treatment predict cardiovascular outcomes and represent a measure of the relative risk reduction in secondary prevention

P Meikle, KS Jayawardana, PA Mundra, PJ Nestel, EH Barnes, A Kirby, P Thompson, DR Sullivan, ZH Alshehry, K Huynh, C Giles, IC Marschner, BA Kingwell, J Simes, AM Tonkin

EUROPEAN HEART JOURNAL | OXFORD UNIV PRESS | Published : 2018

Grants

Awarded by National Health and Medical Research Council of Australia


Funding Acknowledgements

This work was funded by the National Health and Medical Research Council of Australia (grant number 1029754).